180 related articles for article (PubMed ID: 9158102)
1. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice.
Katoh N; Hirano S; Kishimoto S; Yasuno H
Clin Exp Immunol; 1997 May; 108(2):302-8. PubMed ID: 9158102
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of cutaneous immune responses by ATP gamma S: purinergic agonists define a novel class of immunologic adjuvants.
Granstein RD; Ding W; Huang J; Holzer A; Gallo RL; Di Nardo A; Wagner JA
J Immunol; 2005 Jun; 174(12):7725-31. PubMed ID: 15944274
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
Ozawa H; Aiba S; Nakagawa ; Tagami H
Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
[TBL] [Abstract][Full Text] [Related]
4. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
[TBL] [Abstract][Full Text] [Related]
5. Photohapten TCSA painting plus UVA irradiation of murine skin augments the expression of MHC class II molecules and CD86 on Langerhans cells.
Nishijima T; Tokura Y; Imokawa G; Takigawa M
J Dermatol Sci; 1999 Apr; 19(3):202-7. PubMed ID: 10215193
[TBL] [Abstract][Full Text] [Related]
6. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells.
Seiffert K; Hosoi J; Torii H; Ozawa H; Ding W; Campton K; Wagner JA; Granstein RD
J Immunol; 2002 Jun; 168(12):6128-35. PubMed ID: 12055224
[TBL] [Abstract][Full Text] [Related]
7. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells.
Tokura Y; Kobayashi M; Ito T; Takahashi H; Matsubara A; Takigawa M
Cell Immunol; 2003 Jul; 224(1):47-54. PubMed ID: 14572800
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of contact hypersensitivity response in human monocyte chemoattractant protein (MCP)-1 transgenic mice].
Mizumoto N
Hokkaido Igaku Zasshi; 1999 May; 74(3):199-216. PubMed ID: 10422564
[TBL] [Abstract][Full Text] [Related]
9. Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption.
Nishijima T; Tokura Y; Imokawa G; Seo N; Furukawa F; Takigawa M
J Invest Dermatol; 1997 Aug; 109(2):175-82. PubMed ID: 9242504
[TBL] [Abstract][Full Text] [Related]
10. Functional CD40 ligand is expressed on epidermal Langerhans cells.
Salgado CG; Nakamura K; Sugaya M; Tada Y; Asahina A; Koyama Y; Irie S; Tamaki K
J Leukoc Biol; 1999 Aug; 66(2):281-5. PubMed ID: 10449168
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous reactivity of murine epidermal Langerhans cells after application of FITC: a histochemical evaluation.
Doi S; Kobayashi M; Sugiura Y; Sakamoto T; Torii S
Arch Histol Cytol; 1999 Oct; 62(4):363-73. PubMed ID: 10596947
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of immune function during the development of the Langerhans cell network in neonatal mice.
Dewar AL; Doherty KV; Woods GM; Lyons AB; Muller HK
Immunology; 2001 May; 103(1):61-9. PubMed ID: 11380693
[TBL] [Abstract][Full Text] [Related]
13. Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma.
Xiao T; Fujita H; Saeki H; Mitsui H; Sugaya M; Tada Y; Kakinuma T; Torii H; Nakamura K; Asahina A; Tamaki K
Cytokine; 2003 Aug 21-Sep 7; 23(4-5):126-32. PubMed ID: 12967648
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury.
Cooper KD; Duraiswamy N; Hammerberg C; Allen E; Kimbrough-Green C; Dillon W; Thomas D
J Invest Dermatol; 1993 Aug; 101(2):155-63. PubMed ID: 8393901
[TBL] [Abstract][Full Text] [Related]
15. Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1beta.
Cumberbatch M; Dearman RJ; Kimber I
Immunology; 2002 Apr; 105(4):466-77. PubMed ID: 11985667
[TBL] [Abstract][Full Text] [Related]
16. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
Atarashi K; Kabashima K; Akiyama K; Tokura Y
Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells.
Rattis FM; Péguet-Navarro J; Staquet MJ; Dezutter-Dambuyant C; Courtellemont P; Redziniak G; Schmitt D
Eur J Immunol; 1996 Feb; 26(2):449-53. PubMed ID: 8617317
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide.
Torii H; Hosoi J; Beissert S; Xu S; Fox FE; Asahina A; Takashima A; Rook AH; Granstein RD
J Leukoc Biol; 1997 Feb; 61(2):216-23. PubMed ID: 9021928
[TBL] [Abstract][Full Text] [Related]
19. Langerhans' cells in the murine oral mucosa in the inductive phase of delayed type hypersensitivity with 1-chloro-2, 4-dinitrobenzene.
Okamura T; Morimoto M; Yamane G; Takahashi S
Clin Exp Immunol; 2003 Nov; 134(2):188-94. PubMed ID: 14616776
[TBL] [Abstract][Full Text] [Related]
20. Pentamidine isethionate reduces Ia expression and antigen presentation by Langerhans cells and inhibits the contact hypersensitivity reaction.
Blaylock BL; Kouchi Y; Comment CE; Corsini E; Rosenthal GJ; Luster MI
J Immunol; 1991 Oct; 147(7):2116-21. PubMed ID: 1833452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
